Which option to slow myopia? New Clinical Management Infographic

We’re excited to release our new clear, concise and clinically relevant infographic Which option to slow myopia?to help you with what we have learnt is the main practitioner need in myopia management, and the most popular discussion topic in the Myopia Profile Facebook group – guidance in selecting the right treatment for your patient. A world first, evidence based decision …

Read MoreWhich option to slow myopia? New Clinical Management Infographic

Axial length measurement – a clinical necessity?

Most eye care practitioners don’t routinely measure axial length in clinical practice, mainly due to lack of access to the instrumentation and its expense. This is not the only reason, though, that axial length (AXL) measurement is a bit of a problematic measure for gauging myopia management success in a clinical setting. When I was leading the authorship of the …

Read MoreAxial length measurement – a clinical necessity?

Eight Myopia Mysteries (plus eight more!)

This open-access continuing education article I authored was published in Australian professional journal Mivision in December 2018. It describes that while there’s a lot we know about myopia control – the imperative to reduce lifelong risk of vision impairment; that numerous options are available; and that the sooner we start the better – it is imperative for the clinician to …

Read MoreEight Myopia Mysteries (plus eight more!)

Atropine – wonder or weak treatment?

Atropine has been the apparent hero of myopia management since the 2006 publication of the ATOM (atropine for the treatment of childhood myopia) study, which showed an 80% refractive and 100% axial length myopia controlling effect with 1% atropine compared to placebo.1 The significant side effects of mydriasis and cycloplegia, though, made it less than tolerable as a first line …

Read MoreAtropine – wonder or weak treatment?

Four reasons why binocular vision matters in myopia management

Binocular vision is a much neglected (and even maligned?) domain of eye care where I’ve had numerous colleagues say their professional excitement and learning opportunities have been reinvigorated through seeing the clinical imperative and application in practice. Not only does binocular vision assessment add so much more to your clinical picture, and make optometric life more interesting, it could be …

Read MoreFour reasons why binocular vision matters in myopia management

Three clinical pillars for myopia management

Once the myopia management message has been communicated to the parent and patient – information on expectations, efficacy and safety – and the initial correction has been selected, there are three key areas of clinical focus. Firstly, advice on visual environment is useful for both the child at risk of myopia development – those with a family history of myopia …

Read MoreThree clinical pillars for myopia management

Progressive vs bifocal spectacles – which is best?

Podcast summary: Are progressive addition lenses and bifocals created equal for myopia control? How should we pick which lens type to prescribe, and what’s on the horizon for our non-contact lens wearing young myopes? Progressive addition lens (PAL) studies for myopia control show negligible results when single adds are applied to all children, however when applied to children with esophoria …

Read MoreProgressive vs bifocal spectacles – which is best?

Myopia management message part 2 – efficacy

Let’s cut to the chase – until further notice, you can consider low dose (0.01%) atropine, soft multifocal CL’s and OrthoK as all quite similar in terms of their myopia control efficacy, being around 50% on average. A network meta-analysis of sixteen different interventions studied for myopia control showed these options to all have similar efficacy when their refractive and …

Read MoreMyopia management message part 2 – efficacy